Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast CancerDavid Miles, Gilles Romieu, Xavier Pivot et al.|Journal of Clinical Oncology|2010Cited by 887
Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast CancerStephen Chan, P. Fumoleau, Gilles Romieu et al.|Journal of Clinical Oncology|2009Cited by 119